A distinct population of Low-Density Granulocytes with unique features associated with subclinical vascular alterations in Systemic Lupus Erythematosus - Top-Institutions - MDSpire

A distinct population of Low-Density Granulocytes with unique features associated with subclinical vascular alterations in Systemic Lupus Erythematosus

  • By

  • Tobío-Parada, Uxía

  • Rodríguez-Carrio, Javier

  • Martínez-Zapico, Aleida

  • Pérez-Álvarez, Angel I.

  • Suárez-Díaz, Silvia

  • Suárez, Ana

  • López, Patricia

  • May 5, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health – NIAMS
    National Institutes of Health – NIAMS

    Bethesda, MD

    Key Differentiators

    • Rheumatology
    • Autoimmunity

  • #2

    The Johns Hopkins Hospital/Johns Hopkins Medicine
    The Johns Hopkins Hospital/Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Rheumatology

  • #3

    Karolinska Institute
    Karolinska Institute

    Stockholm, Sweden

    Key Differentiators

    • Rheumatology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology

  • #5

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Rheumatology

Original Source(s)

A distinct population of Low-Density Granulocytes with unique features associated with subclinical vascular alterations in Systemic Lupus Erythematosus

  • by Tobío-Parada, Uxía , Rodríguez-Carrio, Javier , Martínez-Zapico, Aleida , Pérez-Álvarez, Angel I., Suárez-Díaz, Silvia , Suárez, Ana , López, Patricia

  • May 5, 2026

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.